Healthbeacon (HBCN.IR) Stock Price

Healthbeacon Price

CLOSED
0
​
Market closed

Revenue has compounded at 13.7% per year over the past 4 years to 2.25 M EUR. Healthbeacon's net margin stands at -588.6%, down from -179.2% several years earlier. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Healthbeacon stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Healthbeacon business model & stock analysis

Healthbeacon PLC, based in Dublin, Ireland, is a digital therapeutics company specializing in managing injectable medications for patients at home. The company operates through Direct-to-Consumer (DTC) and Patient Support Programmes (PSP) segments, offering an Injection Care Management System that tracks medication adherence via AI-driven analytics, reminders, and safe sharps disposal. It serves over 17 countries across Europe, North America, and the UK, delivering technology-enabled waste management and smart medication tools through three distribution channels: PSP, DTC, and Reimbursed Digital Therapeutics.

Frequently asked questions about Healthbeacon

7 analysts currently rate the Healthbeacon stock: 6 recommend buying, 1 holding and 0 selling.

The revenue cannot currently be calculated for Healthbeacon.

The profit cannot currently be calculated for Healthbeacon.

The P/E ratio cannot be calculated for Healthbeacon at the moment.

The P/S cannot be calculated for Healthbeacon currently.

The Eulerpool Quality Score for Healthbeacon is 5/10.

The ISIN of Healthbeacon is IE00014QAJZ5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Healthbeacon is A3C9EA. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Healthbeacon is HBCN.IR. The ticker symbol is used to trade Healthbeacon shares on the stock exchange.

Fair ValueTerminal
148.30 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
35,714.29 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Ireland
Currency
EUR
Initial public offering
Dec 15, 2021
ISIN
IE00014QAJZ5
Cusip
G4404H109
Market capitalization
1.19 M EURMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2023
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.07
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-75.34 %
Last updated Nov 9, 2026, 8:55 AM

Healthbeacon Peer Group

Healthbeacon FIGI

HBCN:ID · BBG013SMLC49HBCNEUR:XS · BBG0142BQY82HBCNEUR:X2 · BBG0142BQY91HBCNEUR:XH · BBG0142BQYD6HBCNEUR:XF · BBG0142BQYG3HBCNEUR:XE · BBG0142BQYJ0HBCNEUR:XJ · BBG0142BQYK8HBCNEUR:XL · BBG0142BQYL7HBCNEUR:XG · BBG0142BQYN5HBCNEUR:XO · BBG0142BQYP3HBCNEUR:XA · BBG0142BQYT9HBCNEUR:E1 · BBG0142BQYW5

All fundamentals and in-depth analysis of Healthbeacon

Our stock analysis for Healthbeacon stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Healthbeacon. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.